News

Botanix Pharmaceuticals stock is on the rise again following release of Quarterly Activities and Cashflow

January 31, 2020/in Latest News /by administrator

https://thegreenfund.com/botanix-pharmaceuticals-stock-is-on-the-rise-again-following-release-of-quarterly-activities-and-cashflow-report

Botanix Pharma – ready for lift-off in 2020

January 13, 2020/in Latest News /by administrator

https://thegreenfund.com/botanix-pharma-ready-for-lift-off

Botanix Pharma launches Rosacea Study

December 9, 2019/in Latest News /by administrator

https://thegreenfund.com/botanix-pharma-launches-rosacea-study

Biotech: Pesky pimple-like rosacea to get Botanix’s Permetrex treatment in early study

December 9, 2019/in Latest News /by administrator

https://stockhead.com.au/health/biotech-pesky-pimple-like-rosacea-to-get-botanixs-permetrex-treatment-in-early-study/

Exploring CBD’s newly found antibacterial properties

December 2, 2019/in Latest News /by administrator

http://www.digitaljournal.com/life/health/exploring-cbd-s-newly-found-antibacterial-properties/article/562771

Botanix announces landmark descheduling of synthetic CBD by DEA

November 25, 2019/in Latest News /by administrator

https://thegreenfund.com/botanix-announces-de-scheduling-of-synthetic-cbd-by-the-dea

Updates on 3 Health Care Stocks – Allegra, Althea and Botanix

November 15, 2019/in Latest News /by administrator

https://kalkinemedia.com/au/blog/whats-latest-with-four-health-care-stocks-heramed-allegra-althea-and-botanix

Botanix Pharma – tell us, is it good or bad?

October 24, 2019/in Latest News /by administrator

https://thegreenfund.com/botanix-pharma-tell-us-is-it-good-or-bad

Botanix announces CBD supply agreement with Purisys

October 21, 2019/in Latest News /by administrator

https://thegreenfund.com/botanix-announces-cbd-supply-agreement-with-purisys

Botanix signs a supply agreement with Purisys

October 21, 2019/in Featured, Latest News /by administrator

Botanix Pharmaceuticals has entered into a supply agreement with Purisys. Purisys has one of the industry’s longest track records and a wide range of offerings in the cannabinoid space. It currently produces all major cannabinoids relevant to pharmaceutical and consumer products. Since 2016, Purisys has also manufactured pharmaceutical-grade cannabidiol at commercial scale utilising a patented process.

Click HERE to read the article on The Market Herald.